Can long-term results following balloon angioplasty be the "crystal ball" to predict outcome following bioresorbable vascular scaffolds?
作者信息
Colombo Antonio, Latib Azeem
出版信息
J Am Heart Assoc. 2012 Oct;1(5):e005272. doi: 10.1161/JAHA.112.005272. Epub 2012 Oct 25.
Abstract
摘要
相似文献
1
Can long-term results following balloon angioplasty be the "crystal ball" to predict outcome following bioresorbable vascular scaffolds?球囊血管成形术后的长期结果能否成为预测生物可吸收血管支架术后结果的“水晶球”？
J Am Heart Assoc. 2012 Oct;1(5):e005272. doi: 10.1161/JAHA.112.005272. Epub 2012 Oct 25.
2
[The bioresorbable coronary scaffold].[生物可吸收冠状动脉支架]
Ned Tijdschr Geneeskd. 2012;156(36):A4994.
3
Bailout left main bioresorbable vascular scaffolding for the treatment of iatrogenic coronary dissection induced by guiding catheter and sticky ABSORB bioresorbable vascular scaffold balloon.用于治疗由引导导管和粘性可吸收生物可降解血管支架球囊引起的医源性冠状动脉夹层的救助左主干生物可吸收血管支架。
Int J Cardiol. 2015;187:527-9. doi: 10.1016/j.ijcard.2015.03.432. Epub 2015 Apr 1.
4
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果：ABSORB 队列 B 试验的光学相干断层成像评估（生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价）。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
5
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较：随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
6
The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug-eluting stent: Current concepts and overview of clinical evidence.ABSORB生物可吸收血管支架：一种新型的、完全可吸收的药物洗脱支架：当前概念及临床证据概述
Catheter Cardiovasc Interv. 2015 Oct;86(4):664-77. doi: 10.1002/ccd.26172.
7
Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials.长期疗效和安全性的依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架：随机临床试验的荟萃分析。
Circ Cardiovasc Interv. 2017 May;10(5). doi: 10.1161/CIRCINTERVENTIONS.117.005286.
8
Percutaneous coronary intervention: balloons, stents and scaffolds.经皮冠状动脉介入治疗：球囊、支架和支架。
Clin Res Cardiol. 2018 Aug;107(Suppl 2):55-63. doi: 10.1007/s00392-018-1328-x. Epub 2018 Jul 23.
9
Bioresorbable Scaffolds for Coronary Artery Disease.用于冠状动脉疾病的生物可吸收支架
Curr Cardiol Rep. 2017 Jan;19(1):5. doi: 10.1007/s11886-017-0812-7.
10
Very late scaffold thrombosis after bioresorbable scaffold implantation: an unexpected new enemy on the horizon… or just a false alarm?
EuroIntervention. 2016 Oct 20;12(9):1077-1079. doi: 10.4244/EIJV12I9A176.
本文引用的文献
1
Very long-term (15 to 23 years) outcomes of successful balloon angioplasty compared with bare metal coronary stenting.与裸金属冠状动脉支架置入术相比，成功的球囊血管成形术的极长期（15 至 23 年）结果。
J Am Heart Assoc. 2012 Oct;1(5):e004085. doi: 10.1161/JAHA.112.004085. Epub 2012 Oct 25.
2
A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study.一项比较紫杉醇药物洗脱球囊与紫杉醇洗脱支架在小冠状动脉中应用的随机多中心研究：BELLO（球囊洗脱和晚期管腔丢失优化）研究。
J Am Coll Cardiol. 2012 Dec 18;60(24):2473-80. doi: 10.1016/j.jacc.2012.09.020. Epub 2012 Nov 14.
3
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?经 ABSORB 依维莫司洗脱生物可吸收血管支架系统治疗的冠状动脉节段中的内皮依赖性血管舒缩与聚合物生物吸收时斑块组成有关：血管修复治疗的间接发现？
Eur Heart J. 2012 Jun;33(11):1325-33. doi: 10.1093/eurheartj/ehr466. Epub 2012 Apr 16.
4
Is the bioresorbable scaffold a sealing device?生物可吸收支架是一种封堵装置吗？
Atherosclerosis. 2012 Mar;221(1):36-7. doi: 10.1016/j.atherosclerosis.2011.12.023. Epub 2011 Dec 26.
5
Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?光学相干断层成像术评估 ABSORB 生物可吸收血管支架置入后新生内膜的环形分布：支架能否覆盖斑块？
Atherosclerosis. 2012 Mar;221(1):106-12. doi: 10.1016/j.atherosclerosis.2011.12.008. Epub 2011 Dec 13.
6
Assimilating the current clinical data of fully bioabsorbable stents.汇总全生物可吸收支架的当前临床数据。
EuroIntervention. 2009 Dec 15;5 Suppl F:F103-8. doi: 10.4244/EIJV5IFA18.
7
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial.在冠心病患者中，可生物降解聚合物比索洛尔洗脱支架与持久性聚合物西罗莫司洗脱支架的长期临床结果（LEADERS）：随机非劣效试验的 4 年随访。
Lancet. 2011 Dec 3;378(9807):1940-8. doi: 10.1016/S0140-6736(11)61672-3. Epub 2011 Nov 8.
8
Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial.在患有新发冠状动脉疾病的患者中，对 ABSORB 依维莫司洗脱可吸收生物血管支架的四年临床随访：ABSORB 试验。
EuroIntervention. 2012 Jan;7(9):1060-1. doi: 10.4244/EIJV7I9A168.
9
The magic of disappearing stents.消失的支架的神奇之处。
J Am Coll Cardiol. 2011 Oct 4;58(15):1589-91. doi: 10.1016/j.jacc.2011.05.049.
10
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.第二代生物可吸收依维莫司洗脱血管支架治疗初发冠状动脉狭窄的评估：12 个月临床和影像学结果。
J Am Coll Cardiol. 2011 Oct 4;58(15):1578-88. doi: 10.1016/j.jacc.2011.05.050.
Zotero 插件